Tag: Drug & Device

We’re Back!

We’re Back!
Share

Here at Seton Hall Law, the halls are filled with the sounds of students again, which means our summer-long blog hiatus has come to an end.  We’re excited to get back to blogging at Health Reform Watch! As always, the blog will feature analysis and commentary from Seton Hall’s health law faculty and Recommended Reading […]

Share

Continue Reading »

Sterilization Matters

Filed in Quality Improvement by on May 31, 2013 4 Comments
Sterilization Matters
Share

When patients undergo surgical or other medical procedures, they hope to receive optimal care provided by experienced physicians. They are rarely concerned about proper sterilization of surgical instruments and other medical equipment as it is likely assumed that the health care facility has applied this standard precaution. Unfortunately, however, not every medical center is adequately […]

Share

Continue Reading »

Recommended Reading: New Legal Scholarship from Ryan Abbott and Jennifer Herbst on Pharmacovigilance Topics

Filed in Health Law, Recommended Reading by on May 14, 2013 2 Comments
Recommended Reading: New Legal Scholarship from Ryan Abbott and Jennifer Herbst on Pharmacovigilance Topics
Share

In his article Big Data and Pharmacovigilance: Using Health Information Exchanges to Revolutionize Drug Safety, which is forthcoming in the Iowa Law Review, Ryan Abbott argues that third parties, including academics, insurance companies, and rival drug companies, should be incentivized via an “administrative bounty proceeding” to analyze the large and rich datasets that will be […]

Share

Continue Reading »

Online Health Law Graduate Certificate Programs

Filed in Health Law by on May 8, 2013 0 Comments
Online Health Law Graduate Certificate Programs
Share
Share

Continue Reading »

Adventures in Health Care Cost Cutting

Filed in Health Reform, Medicaid by on March 17, 2013 0 Comments
Adventures in Health Care Cost Cutting
Share

Expect to keep hearing more talk about health care cost cutting, despite charts like this. It’s an idee fixe of the Wall Street/Washington corridor, and will only be implemented more vigorously over time.  So perhaps we should take stock of a few cost cutting initiatives. Medicare Part D, it seems, is coming way under its […]

Share

Continue Reading »